{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:O95861",
      "entity_text" : "PIP",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P29966",
      "entity_text" : "MARCKS",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Multiple studies have demonstrated that the mammalian MARCKS protein, or more specifically its MARCKS effector domain, can bind to and sequester the phosphoinositide, phosphatidylinositol 4,5-bisphosphate (PIP 2), in artificial lipid vesicles.",
  "reading_complete" : "2020-08-04T14:08:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T14:06:30Z",
  "trigger" : "sequester",
  "evidence" : [ "MARCKS protein, or more specifically its MARCKS effector domain, can bind to and sequester the phosphoinositide, phosphatidylinositol 4,5-bisphosphate (PIP" ],
  "pmc_id" : "4265757",
  "score" : 0
}